The results showed that after BD treatment, the proportion of CD86+CD206− M1 macrophages in diabetic wounds significantly decreased, and the proportion of CD86+CD206+ macrophages and CD86−CD206+ M2 macrophages significantly increased on day 7 (Figs. 1g, h and S4). This evidence concerns the gene MRC1 and Behcet disease.